Ownership of Human Tissues and Cells: New Developments in Biotechnology |
From inside the book
Results 1-5 of 91
Page
New Developments in Biotechnology Office of Technology Assessment United S, United States. Congress. Office of Technology Assessment. Tissues and Cells New Developments in Biotechnology Office of Technology Assessment United States ...
New Developments in Biotechnology Office of Technology Assessment United S, United States. Congress. Office of Technology Assessment. Tissues and Cells New Developments in Biotechnology Office of Technology Assessment United States ...
Page
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page
New Developments in Biotechnology Office of Technology Assessment United S, United States. Congress. Office of Technology Assessment. Ownership of Human Tissues and Cells New Developments in Biotechnology Books for Business New York ...
New Developments in Biotechnology Office of Technology Assessment United S, United States. Congress. Office of Technology Assessment. Ownership of Human Tissues and Cells New Developments in Biotechnology Books for Business New York ...
Page
New Developments in Biotechnology Office of Technology Assessment United S, United States. Congress. Office of Technology Assessment. Ownership of Human Tissues and Cells : New Developments in Biotechnology by Office of Technology ...
New Developments in Biotechnology Office of Technology Assessment United S, United States. Congress. Office of Technology Assessment. Ownership of Human Tissues and Cells : New Developments in Biotechnology by Office of Technology ...
Page
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Common terms and phrases
addition angiogenesis Angiogenin application approved benefits biomedical biotechnology blood cadaver cell culture cell line claim common law consent form consent process courts DHHS diagnostic disclose donations donor ethical factor Federal funded gene probes genetic Health human biological materials human body human research human subjects human tissues hybridoma immune individual informed consent institution Institutional Review Board Interferon Interleukin-2 inventions investigator involving isolated issues liability lymphocyte lymphokines ment mercial molecule monoclonal antibodies moral nonprofit obtained Office of Technology Organ Transplantation organs participation patient payments to sources physician plaintiff potential commercial gain principle procedures protection protein recombinant DNA regulations relationship Res Nullius research subjects result risks sample specific specimens statute substance Supp techniques Technology Assessment terials therapeutic tion tissues and cells tissues or cells tort trade secret transplantation treatment tumor types U.S. Congress University waive